Core Viewpoint - The stock price of Cornerstone Pharmaceuticals-B (02616) increased by 4.79% to HKD 5.69, with a trading volume of HKD 20.56 million, following the announcement of share purchases by CEO Dr. Yang Jianxin [5]. Group 1: Share Purchase Details - On January 27, Cornerstone Pharmaceuticals announced that CEO Dr. Yang Jianxin purchased a total of 976,000 shares in the open market using personal funds between November 2025 and January 2026, with 428,500 shares bought on January 22 and 23, 2026 [5]. - Since taking office as CEO in August 2022, Dr. Yang has cumulatively purchased 12.477 million shares [5]. - After this recent purchase, Dr. Yang holds approximately 4.87% of the company's total issued share capital as of the announcement date [5]. Group 2: Management Confidence - Dr. Yang expressed strong confidence in the long-term investment value and core competitive advantages of the company, indicating that the share purchase reflects his belief in the company's ability to maintain stable operations and high-quality growth in the future [5]. - Dr. Yang does not rule out the possibility of further increasing his shareholding in the company at an appropriate time [5].
基石药业-B午前涨近5% 执行董事杨建新再度增持公司股份